PHILADELPHIA, PA — HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced that it was recognized in three of the July 2023 Gartner Hype Cycles titled: Hype Cycle for Life Science Clinical Development, 2023, Hype Cycle for Life Science Commercial Operations, 2023, and Hype Cycle for Healthcare Data, Analytics and AI, 2023. This is the second year in a row that the company has been recognized in all three of these Hype Cycles and the third consecutive year for Life Science Commercial Operations.

HealthVerity was recognized as a vendor providing several different technology solutions in each of the three Hype Cycles:

Life Science Clinical Development

• Patient data tokenization – According to Gartner, “Patient data tokenization is the process by which clinical trial subjects/patients consent to have their anonymized health information linked to a subject identifier or token. The token can also be linked to existing real-world data (RWD) sources like healthcare claims and laboratory results. This enables life science companies to link patients who have consented to their retrospective RWD, following their activities prospectively for ongoing insights about branded treatments on patient health.” The Gartner report found that this technology is important because, “Patient data tokenization (PDT) enables patient data to be connected between different data sources, enabling life science companies to formulate a holistic, longitudinal view of the patient journey. RWD made available via tokenization can provide significant insight about patient health history, enabling insights about outcomes after a trial, intervention or treatment has been administered by a life science company.”
• RWD-based trials – “Real-world data (RWD)-based trials use RWD to optimize trial activities with applications that deliver improvements to patient recruitment and retention, protocol optimization, trial feasibility, and safety signal detection. As RWD becomes more available, life science companies and vendors are leveraging it to support effective protocol design, precision methods of finding subjects to successfully complete the trial, and improved data capture that leverages patient health records.”
• Data monetization in HCLS – “Data monetization is a practice adopted by a healthcare and life science (HCLS) organization by which they make their proprietary data available to sell to external parties. The most mature examples are payers selling deidentified medical claims data to life science companies. This profile tracks monetization of new data types, utilizing new sharing mechanisms and vendors, targeted at new use cases, which are driving a new cycle of data monetization initiatives.”

Life Science Commercial Operations

• RWD curation and analytics platforms – According to  Gartner, “This technology combines real-world data (RWD), such as electronic health records (EHR), medical and prescription claims, disease and patient registries, lab results, imaging and other sources, to provide a longitudinal view of a patient journey. The platform prepares data for delivery to downstream consumption platforms, applications and analytics. It automates the ingestion and linking of data from permissioned sources, manages identity, compliance and security.”

Healthcare Data, Analytics and AI

• Data sharing in HCLS – “Data sharing in healthcare and life science (HCLS) reflects a broad range of use cases that knit together ecosystem partners to advance clinical care, research and discovery; improve public health; decrease health disparities; and lower costs. Data sharing in HCLS relies on a foundation of interoperability, privacy protecting policies and standards to enable the industry to safely and collaboratively drive new value streams through better data sharing partnerships.”
• Data monetization in HCLS – Defined by Gartner as, “a practice adopted by a healthcare and life science (HCLS) organization by which they make their proprietary data available to sell to external parties. The most mature examples are payers selling deidentified medical claims data to life science companies. This profile tracks monetization of new data types, utilizing new sharing mechanisms and vendors, targeted at new use cases, which are driving a new cycle of data monetization initiatives.”

HealthVerity offers patient data tokenization services with HealthVerity Identity Manager, a leading patient matching and identity resolution technology that is 10x more accurate than legacy tokenization technologies. Identity Manager establishes a unique but persistent HealthVerity ID (HVID) to resolve patient identity over time and across data sources to create a fully interoperable single source of truth. HealthVerity FLOW is a middleware solution that can enable RWD-based clinical trials and be used as a RWD curation and analytics platform that leverages this source of truth capability to enable RWD-driven patient journey initiatives. For example, the platform can synchronize clinical trial participants, their permissions, and the broadest set of identifiable and de-identified data sources in a fully governed, HIPAA-compliant manner to accelerate the time to FDA submission. Additionally, HealthVerity offers data owners the ability to join the nation’s largest healthcare and consumer data ecosystem while managing all aspects of identity resolution, privacy protection and governance of data usage rights for the seamless exchange of unlimited real-world data on HealthVerity Marketplace.

“We are excited to be recognized by Gartner in the Hype Cycle reports,” said HealthVerity COO Andrew Goldberg. “We pride ourselves on offering the life sciences and healthcare sectors transformational technologies that synchronize unparalleled identity management with built-in privacy compliance and governance of data usage rights for the seamless exchange of a near limitless combination of healthcare and consumer data. We believe our inclusion in the Gartner Hype Cycle reports demonstrates the difference these solutions can have on advancing the science.”

GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.

Gartner Disclaimer
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

About HealthVerity

HealthVerity synchronizes transformational technologies with the nation’s largest healthcare and consumer data ecosystem to power previously unattainable outcomes and fundamentally advance the science. We offer a comprehensive, yet flexible approach, based on the foundational elements of Identity, Privacy, Governance and Exchange (IPGE), that synchronizes unparalleled Identity management with built-in Privacy compliance and Governance, providing the ability to discover and Exchange a near limitless combination of data at a record pace. Together with our partners in life sciences, government and insurance, we are Synchronizing the Science. To learn more about HealthVerity, visit healthverity.com.

HealthVerity Contact:

Colleen Stoker
614-738-0592
cstoker@healthverity.com

PHILADELPHIA, PA — HealthVerity, the leader in synchronizing transformational technologies and real-world data (RWD) to advance the science, today announced the general availability of HealthVerity FLOW 1.1 for clinical trials, registries and commercial applications. This latest middleware release revolutionizes the way pharmaceutical manufacturers can integrate RWD with primary data from across the enterprise, offering an end-to-end solution that manages patient identity, governs permissions, and enables on-demand retrieval of HIPAA-compliant data to contextualize patient journeys and drive next-best actions.

HealthVerity FLOW 1.1 is the first pharma-class solution to solve the challenge of seamlessly integrating RWD into key applications, such as clinical trials, as a means to significantly improve the quality and depth of real-world evidence generation. No longer do sponsors or commercial organizations need to rely solely on traditional means for data collection, whether pre- or post-drug launch. With its market-leading capabilities, HealthVerity FLOW effectively tokenizes and manages patient identity as the source of truth with an accuracy rate that is 10x higher than legacy solutions. Furthermore, it can efficiently govern permissions for those same patients as a means to unlock and exchange the broadest ecosystem of both de-identified and identifiable patient data, all in a fully HIPAA-compliant manner.

HealthVerity FLOW 1.1 was designed to expertly synchronize RWD across a wide range of key life sciences use cases:

Enhancing clinical trials: Accelerate pathways to regulatory submissions

HealthVerity FLOW is ideally positioned to provide its clients with an enterprise view of key activities in a single phase II, III or IV trial or across the entire portfolio of clinical trials. By providing a dashboard view of enrollment shared with the application, HealthVerity FLOW can effectively store, manage and report on patient participation as a tokenized source of truth, efficiently manage consents and permissions throughout the duration of a trial, and provide an on-demand means to retrieve de-identified and identifiable data, often the same day, all in a HIPAA-compliant manner and with full data provenance.

This novel approach provides unheralded benefits throughout the trial life cycle:

• During the trial – Augment findings from investigators with regulatory-grade patient data from nationally-recognized sources across medical claims, pharmacy claims, lab data, EHR data and beyond. Whether a patient is actively enrolled or lost to follow up, HealthVerity FLOW offers sponsors a gateway to continue to accurately learn about patient journeys to complement sites and potentially reduce the time to FDA submission.
• After the trial – Seamlessly conduct long-term follow up and post-trial safety surveillance to meet any post-marketing requirements and better understand the safety and efficacy of a product without risking any violation of patient privacy.

Optimizing registries: Efficiently identify potential trial participants

By eliminating many of the complexities of HIPAA-compliant data retrieval, HealthVerity FLOW enables pharma organizations to bring a new richness to key cohorts in patient registries, expanding the breadth of patients available to participate in research studies and optimizing candidate recruitment efforts. HealthVerity FLOW can be deployed to power a sponsor’s own registry efforts or complement the work of hundreds of disease-specific registries across the country.

Enabling commercial success: Gain speed to market for patients in need

HealthVerity FLOW offers unparalleled advantages for commercial organizations seeking to enhance post-launch success. As middleware, HealthVerity FLOW is uniquely positioned to offer a novel means to convert media investment into patient education and acquisition. For example, this state-of-the-art technology enables drug brand websites to capture required permissions to convert web traffic into actionable knowledge about patient intent and priority, all in a privacy-protected and HIPAA-compliant manner.

“HealthVerity FLOW has the power to reveal insights into the patient journey that were never before possible and to do so without additional complexity or strain on clinical trial sites or other pharma resources,” said Andrew Kress, HealthVerity CEO. “We are proud to offer the life sciences industry a comprehensive solution for integrating real-world data that manages patient identity and permissions, enabling on-demand retrieval of both de-identified and identifiable data while ensuring patient privacy and HIPAA compliance. We are truly providing the pathway that pharma needs to drive next-best actions and accelerate the approval of potentially life-saving treatments.”

About HealthVerity

HealthVerity synchronizes transformational technologies with the nation’s largest healthcare and consumer data ecosystem to power previously unattainable outcomes and fundamentally advance the science. We offer a comprehensive, yet flexible approach, based on the foundational elements of Identity, Privacy, Governance and Exchange (IPGE), that synchronizes unparalleled Identity management with built-in Privacy compliance and Governance, providing the ability to discover and Exchange a near limitless combination of data at a record pace. Together with our partners in life sciences, government and insurance, we are Synchronizing the Science. To learn more about HealthVerity, visit healthverity.com.

HealthVerity Contact:

Colleen Stoker
614-738-0592
cstoker@healthverity.com